{
    "nctId": "NCT02580396",
    "briefTitle": "Evaluation Of CanADVICE+\u00aeM-Health System To Support Breast Cancer Patients Receiving Capecitabine",
    "officialTitle": "Evaluation Of CanADVICE+\u00aeM-Health System To Support Breast Cancer Patients Receiving Capecitabine",
    "overallStatus": "COMPLETED",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 16,
    "primaryOutcomeMeasure": "Patient acceptability of the app using questionnaire provided when patients attend for their 3rd cycle and quantified using a 5-point Likert scale",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients diagnosed with metastatic breast cancer\n* Commencing first cycle of Capecitabine\n* Familiar with and own an android smartphone\n* Willing to participate\n\nExclusion Criteria:\n\n* Patients \\<18 years\n* Patients taking part in any other trial containing Capecitabine\n* Chemotherapy-na\u00efve patients",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}